drugset / Trial / NCT00756548

BLI850-302: BLI850 vs an Approved Active Control Bowel Preparation in Adult Subjects Undergoing Colonoscopy

NCT00756548

Phase 3 Completed 386 enrolled Braintree Laboratories
RandomizedParallel-groupSingle-blindTreatment

Summary

This is a randomized, parallel, multi-center, single-blind study, comparing BLI850 to an FDA approved bowel preparation in adult subjects undergoing colonoscopy.

Timeline

Start
2008-08
Primary completion
2008-11
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject BLI850 Unknown Oral
Comparator polyethylene glycol Other / unclassified Oral

Indications